News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–36
Matches
119
Sources here
8
Companies here
24
Search results Stored financial headlines

Active search

119 matching headlines

Ticker or company: BEIMain company stories
Clear
Just inNext headlines
finance.yahoo.com Earnings Main company 🇺🇸 United States

Is BeOne Medicines AG (ONC) Deal With Revolution Medicines (RVMD) a Win-Win for Both Companies?

Two oncology powerhouses, BeOne Medicines AG (NASDAQ:ONC) and Revolution Medicines, Inc. (NASDAQ:RVMD), announced a major multi-part clinical collaboration and regional licensing deal. Under the August 10 agreement, the companies will combine select clinical-stage assets from BeOne with Revolution's four clinical-stage RAS(ON) inhibitors to evaluate …

ONC main company
Sharemaestro market context Price above Trend Line 52 weeks +10.8% ONC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

finance.yahoo.com Earnings Main company 🇺🇸 United States

BeOne Medicines Ltd (ONC) (Q2 2026) Earnings Call Highlights: Revenue Surges 30% to $1. ...

This article first appeared on GuruFocus. Total Revenue: $1.7 billion, representing 30% growth year over year. GAAP Earnings per ADS: $2.05, up 144% compared to the prior year. BRUKINSA Global Revenue: Over $1.2 billion, representing 31% year-over-year growth. US BRUKINSA Sales: $893 million, representing …

ONC main company
Sharemaestro market context Price above Trend Line 52 weeks +10.8% ONC stored weekly price path from 22 Aug 2025 to 14 Aug 2026
富途牛牛 Analyst action Main company 🇺🇸 United States

BOCOM International: BeiGene maintains 'Buy' rating with target price raised to HK$276

BOCOM International has maintained its 'Buy' rating for BeiGene, increasing the target price to HK$276. This reflects a positive outlook on the biopharmaceutical company's future performance and valuation.

ONC main company
Sharemaestro market context Price above Trend Line 52 weeks +10.8% ONC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context